Who we can help
A closer look at your exposure.
Laboratories, medical-product businesses, pharmaceutical companies, clinical-trial sponsors and life-sciences distributors.
Research, clinical testing, manufacturing and commercialization involve different responsibilities. Product use, trial territory, regulatory status and contractual indemnities can materially change the risk.
What to discuss with your broker
Products & professional liability
Review the intended use of products, advice provided and responsibility for design or testing.
Clinical trials
Discuss trial protocols, participating countries, sponsors and contractual insurance requirements.
Property & specialist stock
Consider laboratory equipment, temperature-sensitive stock and contamination exposures.
Interruption & recall
Review supply dependencies, product withdrawal scenarios and recovery time after a loss.
These are areas to consider, not a promise of coverage. Options, exclusions, limits and availability depend on the insurer and your circumstances.
Have a useful first conversation.
If available, have the following information ready. Your broker will tell you what is needed for a formal submission.
- Product pipeline, intended uses and regulatory status
- Clinical trial protocols, territories and contracts where applicable
- Revenue, manufacturing partners and quality systems
- Stock values, temperature controls and prior incidents
A question worth asking
Should insurance be reviewed before a trial starts?
Yes. Trial-specific requirements, territory and contractual wording should be reviewed early enough to arrange any required evidence of insurance before participants are enrolled.